ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

REGN Regeneron Pharmaceuticals Inc

883.20
-7.48 (-0.84%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-7.48 -0.84% 883.20 17:08:31
Open Price Low Price High Price Close Price Previous Close
881.72 875.225 887.4794 883.20 890.68
more quote information »

Recent News

Date Time Source Heading
4/25/202406:00GLOBERegeneron and Mammoth Biosciences Collaborate to Pursue..
4/24/202409:05GLOBERegeneron to Showcase Progress in Advancing Novel..
4/22/202416:54GLOBERegeneron to Highlight Advances in Genetic Medicine Research..
4/16/202406:18IHMARKETNEWSEricsson Soars with 66% Net Profit Growth; Live Nation Under..
4/11/202406:24IHMARKETNEWSCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’..
4/07/202415:00GLOBELinvoseltamab Pivotal Data Presented at AACR Reinforce High..
4/01/202415:05GLOBERegeneron to Report First Quarter 2024 Financial and..
3/25/202406:00GLOBERegeneron Provides Update on Biologics License Application..
3/12/202422:55PRNUSHigh School Seniors Win $1.8 Million at Regeneron Science..
3/12/202420:30GLOBEHigh School Seniors Win $1.8 Million at Regeneron Science..
3/11/202406:00GLOBEPraluent® (alirocumab) Injection Receives FDA Approval to..
3/08/202406:00GLOBEEYLEA® HD (aflibercept) Injection 8 mg Pivotal Data in Wet..
3/05/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202415:14EDGAR2Form 144 - Report of proposed sale of securities
2/28/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202415:34EDGAR2Form 144 - Report of proposed sale of securities
2/26/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202415:07EDGAR2Form 144 - Report of proposed sale of securities
2/26/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202414:25EDGAR2Form 144 - Report of proposed sale of securities
2/23/202415:04EDGAR2Form 144 - Report of proposed sale of securities
2/23/202400:00GLOBEDupixent® (dupilumab) sBLA Accepted for FDA Priority Review..
2/22/202416:10EDGAR2Form 144 - Report of proposed sale of securities
2/22/202415:06EDGAR2Form 144 - Report of proposed sale of securities
2/21/202406:00GLOBELinvoseltamab BLA for Treatment of Relapsed/Refractory..
2/20/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/15/202423:59GLOBEJapan First in the World to Approve Dupixent® (dupilumab)..
2/14/202416:08EDGAR2Form 144 - Report of proposed sale of securities
2/12/202415:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202415:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202417:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/09/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202415:04EDGAR2Form 144 - Report of proposed sale of securities
2/09/202411:22EDGAR2Form 144 - Report of proposed sale of securities
2/08/202415:56EDGAR2Form 144 - Report of proposed sale of securities
2/08/202415:26EDGAR2Form 144 - Report of proposed sale of securities
2/08/202415:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/08/202415:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/07/202416:59EDGAR2Form 144 - Report of proposed sale of securities
2/07/202416:07EDGAR2Form 144 - Report of proposed sale of securities
2/07/202415:35EDGAR2Form 144 - Report of proposed sale of securities
2/06/202415:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/06/202415:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/06/202415:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/06/202415:05GLOBERegeneron Announces Investor Conference Presentations

Your Recent History

Delayed Upgrade Clock